CHAMPIONS ONCOLOGY INC (CSBR)

US15870P3073 - Common Stock

5.13  +0.26 (+5.36%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
41.04M
27.77%		49.11M
19.66%		53.87M
9.69%		49.822M
-7.51%
EBITDA
YoY % growth
1.55M
346.03%		2.24M
44.52%		-2.2M
-198.21%		-6.69M
-204.10%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
370K
125.34%		610K
64.86%		-4.45M
-829.51%		-9.692M
-117.80%
Operating Margin
0.90%1.24%-8.26%-19.45%
EPS
YoY % growth
0.02
114.29%		0.03
50.00%		-0.39
-1,400.00%		-0.64
-64.77%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.16
14.11%
Revenue
Q2Q % growth		12.946M
-0.95%
EBITDA
Q2Q % growth		-1.741M
EBIT
Q2Q % growth		-2.466M
-44.23%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.16
11.11%		-0.06-0.10-161.44%
Q2 2024
Q2Q % growth		 -0.15
-∞%		-0.170.0213.49%
Q1 2024
Q2Q % growth		 -0.19
-850.00%		-0.12-0.07-61.98%
Q4 2023
Q2Q % growth		 -0.19
-533.33%		-0.13-0.06-49.02%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 12.019M
-5.88%		13.746M-1.727M-12.56%
Q2 2024
Q2Q % growth		 11.573M
-18.96%		13.101M-1.528M-11.66%
Q1 2024
Q2Q % growth		 12.56M
-8.65%		13.326M-766K-5.75%
Q4 2023
Q2Q % growth		 13.07M
1.48%		13.117M-47K-0.36%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -255.56% -27.27% -27.27%
Revenue0% -17.82% 0% -11.43%